Halozyme Therapeutics | HALO - Eps Utile Per Azione


Fiscal Calendario Efettivo Consenso Precedente Data
FY2026Q1 Mar/2026 1.60 1.76 1.11 May/11
FY2025Q4 Dec/2025 -0.24 1.9 1.26 Feb/17
FY2025Q3 Sep/2025 1.72 1.59 1.27 Nov/03
FY2025Q2 Jun/2025 1.54 1.21 0.91 Aug/05
FY2025Q1 Mar/2025 1.11 0.96 0.79 May/06




Eps Cambiamento Data
Acadia Pharmaceuticals USD 0.02 1.58 2026-03
Agios Pharmaceuticals USD -1.69 0.17 2026-03
Alnylam Pharmaceuticals USD 1.99 0.74 2026-03
Amarin USD 0.14 0.06 2025-12
Amgen USD 5.15 0.14 2026-03
Baxter International USD 0.36 0.08 2026-03
Cara Therapeutics USD -0.59 4.45 2025-09
Cytokinetics USD -1.67 0.17 2026-03
DBV Technologies USD -0.24 1.31 2025-09
Eli Lilly USD 8.55 1.01 2026-03
Esperion Therapeutics USD 0.26 0.42 2025-12
Halozyme Therapeutics USD 1.6 1.84 2026-03
Intrexon USD -0.1 0.03 2024-06
Ionis Pharmaceuticals USD -0.56 0.85 2026-03
MannKind USD -0.02 0.03 2026-03
Minerva Neurosciences USD -0.56 3.53 2024-12
Nektar Therapeutics USD -1.35 1.17 2025-12
Pfizer USD 0.75 0.09 2026-03
Rigel Pharmaceuticals USD 0.7 0.76 2024-09
United Therapeutics USD 5.82 1.88 2026-03
Vanda Pharmaceuticals USD -0.09 0 2024-12